首页 | 本学科首页   官方微博 | 高级检索  
检索        

脂必妥与多烯康治疗高脂血症各54例的比较
引用本文:晋万强,李臣文,徐梅,高迎香,徐新伟.脂必妥与多烯康治疗高脂血症各54例的比较[J].中国新药与临床杂志,1997(1).
作者姓名:晋万强  李臣文  徐梅  高迎香  徐新伟
作者单位:潍坊市人民医院
摘    要:目的:比较脂必妥与多烯康治疗高脂血症的疗效。方法:高脂血症108例分为2组。脂必妥组54例(男性37例,女性17例;年龄48±s7a),给脂必妥片1.05g,po,tid,共4wk。多烯康组(男性36例,女性18例;年龄48±8a),给多烯康1.35g,po,tid×4wk。结果:脂必妥组用药2wk开始TC,TG,LDL-ch,均有显著下降(P<0.01),HDL-ch显著升高(P<0.05);用药4wk均进一步下降或升高。多烯康组用药2wk和4wk后TC,TG,LDL-ch亦有显著下降(P<0.01),HDL-ch无显著变化。结论:脂必妥调脂作用优于多烯康。

关 键 词:脂必妥  多烯康  血脂过多  脂蛋白类

Zhi-bi-tuo vs Duo-xi-kang in treating hyperlipidemia each 54 patients
JIN Wan-Qiang,LI Chen-Wen,XU Mei,GAO Ying-Xiang,XU Xin-Wei.Zhi-bi-tuo vs Duo-xi-kang in treating hyperlipidemia each 54 patients[J].Chinese Journal of New Drugs and Clinical Remedies,1997(1).
Authors:JIN Wan-Qiang  LI Chen-Wen  XU Mei  GAO Ying-Xiang  XU Xin-Wei
Abstract:AIM: To study the efficacy of Zhi-bi-tuo(ZBT) tablet and Duo-xi-kang (DXK)capsule in treating hyperlipidemia. METHODS: One hundred and eight hyperlipidemia patients were randomly divided into 2 groups. 54 patients (M 37, F 17; age 48±s 7 a) received ZBT 1.05 g, po, tid, for 4 wk. 54 patients in DXK group (M 36, F 18; age 48±8 a) received DXK 1.35 g, po, tid, for 4 wk. RESULTS: In ZBT group: TC, TG, and LDL-ch were decreased and HDL-ch was increased remarkably (P<0.01) after received ZBT 2 wk. TC, TG, LDL-ch and HDL-ch were decreased or increased further more after 4 wk. In DXK group: TC, TG, and LDL-ch were also decreased remarkably (P<0.01), but HDL-ch had no marked change after received DXK 2 wk or 4 wk. CONCLUSION: ZBT is better than DXK in the efficacy of lipid-adjusting.
Keywords:Zhi-bi-tuo  Duo-xi-kang  hyperlipidemia  lipoproteins
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号